Plasma GLP1 and Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention

Efficacy Study of Glucagonlike Peptide-1 to Treat Reperfusion Injury

NCT02001363 ·Status: UNKNOWN ·Phase: NA

Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters

NCT02490176 ·Status: UNKNOWN ·Phase: NA

Cardiovascular Outcomes and HbA1c Among Patients With Type 2 Diabetes Newly Initiating GLP1RAs vs Basal Insulin

NCT04034524 ·Status: UNKNOWN

Effect of GLP-1 Receptor (GLP-1R) Agonists on Cardiac Function and on Epicardial Adipose Tissue (EAT) Volume and on Myocardial TG Content in Obese Diabetics

NCT02042664 ·Status: COMPLETED ·Phase: PHASE3

GLP-1 Loading During Elective Percutaneous Coronary Intervention

NCT02127996 ·Status: UNKNOWN ·Phase: PHASE2

GLP-1 Receptor Agonist for Reduction of Myocardial Injury After Non-cardiac Surgery

NCT06324461 ·Status: RECRUITING ·Phase: PHASE4

Cardioprotective Effects of GLP-1 and Their Mechanisms

NCT02128022 ·Status: COMPLETED ·Phase: PHASE1

GLP-1RAs) and SGLT2is Combination Therapy and MACEs in Patients with Type 2 Diabetes.

NCT06017544 ·Status: COMPLETED

The Role of Glucagon-Like Peptide-1 Receptor Agonists in Coronary Artery Diseases and Their Potential Mechanisms

NCT07073053 ·Status: NOT_YET_RECRUITING ·Phase: PHASE4

Effect of 48 Hours of Treatment With the Natural Peptide-Hormone GLP-1 in Patients With Chronic Heart Failure

NCT00264199 ·Status: COMPLETED ·Phase: NA

Effects of GLP-1 on Chronic Heart Failure

NCT02650596 ·Status: UNKNOWN ·Phase: NA

Human Vasodilatory Effect of GLP-1

NCT03502083 ·Status: COMPLETED ·Phase: NA

Diastolic RV EvAluation With Millar Catheter to Investigate the Effect of Glucagon-Like Peptide-1 (GLP-1) on Right Ventricular Function During Elective Coronary Angioplasty and Stenting

NCT02236299 ·Status: UNKNOWN ·Phase: NA

Glucagon-like Peptide-1 and Coronary Microvascular Dysfunction in Women With Angina Pectoris and no Coronary Stenosis

NCT02602600 ·Status: COMPLETED ·Phase: PHASE4

Clinical Study of Liraglutide in Improving Cardiac Function for Patients With Ischemic Cardiomyopathy

NCT02930265 ·Status: UNKNOWN ·Phase: NA

The Effect of GLP-1 on Glucose Uptake in the Brain and Heart in Healthy Men During Hypoglycemia

NCT00418288 ·Status: COMPLETED ·Phase: NA

Cooperation of Insulin and GLP-1 on Myocardial Glucose Uptake

NCT01232946 ·Status: COMPLETED ·Phase: NA

Effects of Hyperglycemia on Myocardial Perfusion in Humans With and Without Type 2 Diabetes

NCT01021865 ·Status: COMPLETED

The Effect of Glucagon-Like Peptide-1 (GLP-1) on Pulmonary Vascular Resistance (PVR) in Patients With Heart Failure

NCT02129179 ·Status: COMPLETED ·Phase: PHASE1

Endothelial and Metabolic Effects of Glucagon-like Peptide-1 (GLP-1) in Coronary Circulation in Patients With Type 2 Diabetes Mellitus

NCT00923962 ·Status: COMPLETED ·Phase: NA

Effect of Intact GLP-1 (7-36) and GLP-1 Metabolite (9-36) on Coronary and Peripheral Vascular Function in Adults

NCT02333591 ·Status: COMPLETED ·Phase: PHASE4

GLP-1 and Hypoglycemia

NCT01858896 ·Status: ACTIVE_NOT_RECRUITING ·Phase: EARLY_PHASE1

Effect of Glucagon-like Peptide 1 (GLP-1) on Microvascular Myocardial Function in Patients With Type 2 Diabetes.

NCT01931982 ·Status: COMPLETED ·Phase: PHASE4

Effect of a Glucagon Like Peptide 1 (GLP1) Booster in Healthy Humans

NCT06333496 ·Status: COMPLETED ·Phase: NA

To Determine the Effect of GLP1 on Cognitive Function, Brain Glucose Metabolism and Neuroplasticity.

NCT03414333 ·Status: COMPLETED ·Phase: NA